A Phase 1 Bioequivalence Study Between the Current Commercial Capsule and the Proposed Soft Gel Capsule of Talazoparib, and Food Effect Study for the Proposed Talazoparib Soft Gel Capsule in Participants With Advanced Solid Tumors. A Phase 1, Open Label, Crossover Study to Establish Bioequivalence Between the Proposed Soft Gel Talazoparib Capsule Formulation and the Current Talazoparib Commercial Formulation and to Estimate the Food Effect on Pharmacokinetics of the Proposed Talazoparib Soft Gel Capsule Formulation in Participants With Advanced Solid Tumors.